Targeting PIK3CA and CDKN2A alterations in Esophageal Adenocarcinoma with Alpelisib and Palbociclib

被引：0
|
作者：
Rustgi, Naryan
Ryan, Thomas
Cho, Jin
Moy, Ryan
Yoon, Sam
Ryeom, Sandra
Yoon, Changhwan
机构：
来源：
MOLECULAR CANCER THERAPEUTICS | 2023年 / 22卷 / 12期
关键词：
D O I：
10.1158/1535-7163.TARG-23-C157
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
C157
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Synergistic actions of Alpelisib and Melatonin in breast cancer cell lines with PIK3CA gene mutation
    de Godoy, Bianca Lara Venancio
    Moschetta-Pinheiro, Marina Gobbe
    Chuffa, Luiz Gustavo de Almeida
    Ponde, Noam Falbel
    Reiter, Russel J.
    Colombo, Jucimara
    Zuccari, Debora Aparecida Pires de Campos
    LIFE SCIENCES, 2023, 324
  • [32] Targeting glutamine addiction of PIK3CA mutant colorectal cancers
    Zhao, Yiqing
    CANCER RESEARCH, 2017, 77
  • [33] Effects of palbociclib on oral squamous cell carcinoma and the role of PIK3CA in conferring resistance
    Nur Syafinaz Zainal
    Bernard Kok Bang Lee
    Zheng Wei Wong
    Iuan Sheau Chin
    Pei San Yee
    Chai Phei Gan
    Kein Seong Mun
    Zainal Ariff Abdul Rahman
    JSilvio Gutkind
    Vyomesh Patel
    Sok Ching Cheong
    Cancer Biology & Medicine, 2019, (02) : 264 - 275
  • [34] Effects of palbociclib in oral squamous cell carcinoma and the role of PIK3CA in conferring resistance
    Zainal, Nur Syafinaz
    Lee, Bernard Kok Bang
    Wong, Zheng Wei
    Chin, Iuan Sheau
    Yee, Pei San
    Gan, Chai Phei
    Mun, Kein Seong
    Rahman, Zainal Ariff Abdul
    Gutkind, J. Silvio
    Patel, Vyomesh
    Cheong, Sok Ching
    CANCER BIOLOGY & MEDICINE, 2019, 16 (02) : 264 - +
  • [35] Activity of alpelisib in a panel of breast XPDX models harboring hotspot and uncommon PIK3CA mutations
    Castaneda, Mercedes
    Simonson, Alyssa
    Flores, Johnnie
    DeBoer, Maci
    Lund, Jim
    Rouzbahan, Tahmi
    Papadopoulos, Kyriakos P.
    Lang, Amy
    Rodriguez, Gladys
    Elmi, Maryam
    Rosenthal, Arthur
    Rasco, Drew
    Moreno, Victor
    Patnaik, Amita
    Hernandez, Tatiana
    Calvo, Emiliano
    Smith, Lon
    Sharma, Manish
    Beeram, Muralidhar
    Wick, Michael
    CANCER RESEARCH, 2024, 84 (09)
  • [36] Role of EGFR, HER2 and PIK3CA alterations in male breast cancer
    Rizzolo, P.
    Silvestri, V.
    Falchetti, M.
    Zanna, I.
    Palli, D.
    Ottini, L.
    EJC SUPPLEMENTS, 2010, 8 (05): : 24 - 24
  • [37] Mutation analysis of PIK3CA and PIK3CB in esophageal cancer and Barrett's esophagus
    Phillips, WA
    Russell, SE
    Ciavarella, ML
    Choong, DYH
    Montgomery, KG
    Smith, K
    Pearson, RB
    Thomas, RJS
    Campbell, IG
    INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (10) : 2644 - 2646
  • [38] PIK3CA mutation status in Japanese esophageal squamous cell carcinoma
    Mori, Ryota
    Ishiguro, Hideyuki
    Kimura, Masahiro
    Mitsui, Akira
    Sasaki, Hidefumi
    Tomoda, Keisuke
    Mori, Yoichiro
    Ogawa, Ryo
    Katada, Takeyasu
    Kawano, Osamu
    Harada, Koshiro
    Fujii, Yoshitaka
    Kuwabara, Yoshiyuki
    JOURNAL OF SURGICAL RESEARCH, 2008, 145 (02) : 320 - 326
  • [39] Proteomic alterations in extracellular vesicles induced by oncogenic PIK3CA mutations
    Saraswat, Mayank
    Garapati, Kishore
    Kim, Jinyong
    Budhraja, Rohit
    Pandey, Akhilesh
    PROTEOMICS, 2022, 22 (19-20)
  • [40] PIK3CA mutation in colorectal cancer:: Relationship with genetic and epigenetic alterations
    Nosho, Katsuhiko
    Kawasaki, Takako
    Ohnishi, Mutsuko
    Suemoto, Yuko
    Kirkner, Gregory J.
    Zepf, Dimity
    Yan, Liying
    Longtine, Janina A.
    Fuchs, Charles S.
    Ogino, Shuji
    NEOPLASIA, 2008, 10 (06): : 534 - 541
12345